BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 17360583)

  • 1. Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters.
    Dong E; Guidotti A; Grayson DR; Costa E
    Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4676-81. PubMed ID: 17360583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia.
    Dong E; Agis-Balboa RC; Simonini MV; Grayson DR; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12578-83. PubMed ID: 16113080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice.
    Tremolizzo L; Doueiri MS; Dong E; Grayson DR; Davis J; Pinna G; Tueting P; Rodriguez-Menendez V; Costa E; Guidotti A
    Biol Psychiatry; 2005 Mar; 57(5):500-9. PubMed ID: 15737665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation.
    Dong E; Nelson M; Grayson DR; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13614-9. PubMed ID: 18757738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability.
    Tremolizzo L; Carboni G; Ruzicka WB; Mitchell CP; Sugaya I; Tueting P; Sharma R; Grayson DR; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):17095-100. PubMed ID: 12481028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling.
    Guidotti A; Dong E; Kundakovic M; Satta R; Grayson DR; Costa E
    Trends Pharmacol Sci; 2009 Feb; 30(2):55-60. PubMed ID: 19110320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic subtypes can be characterized by differences in their ability to modify GABAergic promoter methylation.
    Dong E; Grayson DR; Guidotti A; Costa E
    Epigenomics; 2009 Oct; 1(1):201-11. PubMed ID: 22122643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate induces DNA demethylation in nuclear extracts from adult mouse brain.
    Dong E; Chen Y; Gavin DP; Grayson DR; Guidotti A
    Epigenetics; 2010; 5(8):730-5. PubMed ID: 20716949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methyltransferase inhibitors coordinately induce expression of the human reelin and glutamic acid decarboxylase 67 genes.
    Kundakovic M; Chen Y; Costa E; Grayson DR
    Mol Pharmacol; 2007 Mar; 71(3):644-53. PubMed ID: 17065238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of RELN and GAD1 in the frontal cortex (FC) of autism spectrum disorder (ASD) subjects.
    Zhubi A; Chen Y; Guidotti A; Grayson DR
    Int J Dev Neurosci; 2017 Nov; 62():63-72. PubMed ID: 28229923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA-methyltransferase1 (DNMT1) binding to CpG rich GABAergic and BDNF promoters is increased in the brain of schizophrenia and bipolar disorder patients.
    Dong E; Ruzicka WB; Grayson DR; Guidotti A
    Schizophr Res; 2015 Sep; 167(1-3):35-41. PubMed ID: 25476119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes.
    Kundakovic M; Chen Y; Guidotti A; Grayson DR
    Mol Pharmacol; 2009 Feb; 75(2):342-54. PubMed ID: 19029285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased binding of MeCP2 to the GAD1 and RELN promoters may be mediated by an enrichment of 5-hmC in autism spectrum disorder (ASD) cerebellum.
    Zhubi A; Chen Y; Dong E; Cook EH; Guidotti A; Grayson DR
    Transl Psychiatry; 2014 Jan; 4(1):e349. PubMed ID: 24448211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia.
    Grayson DR; Chen Y; Costa E; Dong E; Guidotti A; Kundakovic M; Sharma RP
    Pharmacol Ther; 2006 Jul; 111(1):272-86. PubMed ID: 16574235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors decrease reelin promoter methylation in vitro.
    Mitchell CP; Chen Y; Kundakovic M; Costa E; Grayson DR
    J Neurochem; 2005 Apr; 93(2):483-92. PubMed ID: 15816871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases.
    Simonini MV; Camargo LM; Dong E; Maloku E; Veldic M; Costa E; Guidotti A
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1587-92. PubMed ID: 16432198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains.
    Veldic M; Caruncho HJ; Liu WS; Davis J; Satta R; Grayson DR; Guidotti A; Costa E
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):348-53. PubMed ID: 14684836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABAergic dysfunction in mGlu7 receptor-deficient mice as reflected by decreased levels of glutamic acid decarboxylase 65 and 67kDa and increased reelin proteins in the hippocampus.
    Wierońska JM; Brański P; Siwek A; Dybala M; Nowak G; Pilc A
    Brain Res; 2010 Jun; 1334():12-24. PubMed ID: 20353761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of melatonin on prenatal dexamethasone-induced epigenetic alterations in hippocampal morphology and reelin and glutamic acid decarboxylase 67 levels.
    Lui CC; Hsu MH; Kuo HC; Chen CC; Sheen JM; Yu HR; Tiao MM; Tain YL; Chang KA; Huang LT
    Dev Neurosci; 2015; 37(2):105-14. PubMed ID: 25720733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic modifications of GABAergic interneurons are associated with the schizophrenia-like phenotype induced by prenatal stress in mice.
    Matrisciano F; Tueting P; Dalal I; Kadriu B; Grayson DR; Davis JM; Nicoletti F; Guidotti A
    Neuropharmacology; 2013 May; 68():184-94. PubMed ID: 22564440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.